Keyphrases
Healthy Volunteers
100%
Magnesium
100%
Platelet Activity
100%
Infusion Study
100%
Magnesium Sulfate
40%
Nitric Oxide Release
30%
Tissue Plasminogen Activator (t-PA)
20%
Platelet Aggregation
20%
Fibrinolytic Activity
20%
PGI2
20%
Bleeding Time
20%
Placebo-controlled
10%
Preeclampsia
10%
Controlled Crosses
10%
Beneficial Effects
10%
Acute Myocardial Infarction
10%
Blood Pressure
10%
Healthy Males
10%
Hemodynamic Parameters
10%
Prostacyclin
10%
Collagen
10%
In Vivo Effects
10%
Vessel Wall
10%
Prostaglandins
10%
Plasminogen Activator inhibitor-1 (PAI-1)
10%
Bolus Infusion
10%
In Vitro Study
10%
Thrombus Formation
10%
Urinary Concentration
10%
Intravenous Bolus
10%
Experimental Animal Studies
10%
One Sample
10%
β-thromboglobulin
10%
Thromboxane B2 (TXB2)
10%
Plasma beta
10%
Platelet-rich Plasma
10%
Keto
10%
Antiplatelet Activity
10%
Platelet Reactivity
10%
Nitrate Concentration
10%
Magnesium Concentration
10%
Arterial Thrombus
10%
Human Measurement
10%
Biochemistry, Genetics and Molecular Biology
Normal Human
100%
Platelet
100%
Nitric Oxide
75%
Fibrinolysis
50%
Tissue Plasminogen Activator
50%
Thrombocyte Aggregation
50%
Bleeding Time
50%
Blood Pressure
25%
Hemodynamic
25%
Prostaglandin
25%
Coagulation System
25%
Animal Experiment
25%
Prostacyclin
25%
Kidney Concentrating Capacity
25%
Adenosine Diphosphate
25%
Plasminogen Activator Inhibitor-1
25%
Beta-Thromboglobulin
25%
Experimental Animal
25%
Magnesium Sulfate
25%
Platelet-Rich Plasma
25%
In Vitro Study
25%
Thromboxane B2
25%
Platelet Reactivity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
100%
Nitric Oxide
100%
Fibrinolytic Agent
66%
Tissue Plasminogen Activator
66%
Placebo
33%
Preeclampsia
33%
Acute Heart Infarction
33%
Bleeding
33%
Antiplatelet
33%
Adenosine Diphosphate
33%
Plasminogen Activator Inhibitor
33%
Prostacyclin
33%
Experimental Animal
33%
Beta Thromboglobulin
33%
Magnesium Sulfate
33%
Artery Thrombosis
33%
2,3 Dinor 6 Oxoprostaglandin F1 Alpha
33%
2,3 Dinorthromboxane B2
33%
Medicine and Dentistry
Volunteer
100%
Infusion
100%
Magnesium
100%
Platelet
100%
Nitric Oxide
27%
Fibrinolysis
18%
Tissue Plasminogen Activator
18%
Thrombocyte Aggregation
18%
Bleeding Time
18%
Placebo
9%
Blood Pressure
9%
Pre-Eclampsia
9%
Acute Heart Infarction
9%
In Vitro
9%
Hemodynamic
9%
Antiplatelet
9%
Ex Vivo
9%
Prostacyclin
9%
Blood Clotting
9%
Adenosine Diphosphate
9%
Plasminogen Activator Inhibitor
9%
Artery Thrombosis
9%
Kidney Concentrating Capacity
9%
Beta Thromboglobulin
9%
Magnesium Sulfate
9%
Thrombocyte Rich Plasma
9%
Platelet Reactivity
9%
2,3 Dinorthromboxane B2
9%
2,3 Dinor 6 Oxoprostaglandin F1 Alpha
9%